Monoamine oxidases were assayed in live Trypanosoma brucei brucei and in trypanosomal homogenate using the oxygen electrode method. Serotonin and tryptamine were used as standard monomine oxidase A and B substrates, respectively. The ability of live trypanosomes to metabolize tryptamine and serotonin was also monitored by the more sensitive high performance liquid chromatography method. No measurable enzyme activity could be detected in either live trypanosomes or trypanosomal cell homogenates. These results obtained s uggest that T . b . b rucei do not p ossess monoamine o xidase a ctivity. Thus trypanocidal tryptophan analogs that were previously thought to act through inhibition of monoamine metabolizing enzymes may be acting by a diferent mechanism. The activity of these tryptophan analogs against mammalian M A 0 was tested to establish their potential toxicity in man. Two compounds, 5-(l-benzenesulphonylindol-2-ylidene)-5-methoxy-3-ethylthiazolidene-2-thione and
INTRODUCTION
Trypanosomes causing African trypanosomiasis are known to have a high capacity to catabolize aromatic amino acids [1, 2] . Tryptophan, for instance is broken down to the indole pyruvate, indole lactate and indole-3-ethanol via the aminotransferase pathway [3, 4] . Indole-3-ethanol is neuroactive and is thought to induce the CNS pathology observed in the later stages of trypanosomiasis [5-71. Mammalian enzymes on the other hand catabolize trytophan using monoamine oxidase (MAO) to tryptamine, 5-hydroxytryptamine (serotoning, 5 -HT) and melatonin among other products [7] . However, it has not been shown whether the trypanosomes produce these products and are able to metabolize them further [I-41. It is noteworthy that tryptamine, 5-HT and their metabolites are neuroactive and could contribute to the pathogenesis of trypanosomiasis [8].
Certain amino acid analogs possess trypanocidal properties. Dithroromethyl orhithine (DFMO) is marketed for treatment of Typanosoma rhodesiense infection [9] . The trypanocidal potential of synthetic tryptophan analogs has been reported previously [lo] . In the present study, we set out to determine whether the activity of nine tryptophan analogs (figure 1) can be attributed to inhibition of parasite MAO.
EXPERIMENTAL

Buffers
HGRP buffer for maintenance of T b . brucei during the experiments consisted of Nhydmxyethylpiperazine -N'-2-ethanesulphonic acid sodium, HEPES (25 mM), Na2HP04 (30 mM), Ca(N03)2 (0.42 mM), KC1 (5.4mM), MgS04 (0.41 mM), NaCl (100 mM), glucose (56 rnM), pH 7.4.
* Author to whom correspondence may be addressed. .
Homogenizing b uffer was u sed during p arasite and liver tissue homogenization with the aid of acid washed beads. It consisted of sucrose (250 mM) and TFUS (10 rnM for parasite and 3.4 mM for liver homogenates respectively).
Liver tissue
Two Witstar rats (male and female), were sacrificed and their livers removed and washed in ice-cold homogenizing buffer to remove excess blood before use.
Oxygen consumption by T.b. brucei
Trypanosoma brucei brucei trypomastigotes (S4 2711 18) were obtained from infected rat blood [I 11 and maintained i n H GRP b uffer. The rate of oxygen consumption was measured for 2 minutes using a Clarke-type oxygen electrode in astirred solutionkeptat 37"C [12] . Thiswas carried both with and without the M A 0 substrates, tryptamine and 5-HT. During the experiment oxygen utilization via the glycerol phosphate was arrested by use of salicylhydroxamic acid. The presence of oxygen was confirmed by addition of dithionate.
M A 0 activity of T. b. brucei homogenates
Purified trypanozmes were homogenized in homogenizing buffer and acid washed beads. The homogenate was treated to centrifugation and protein content determination by the Biorad protein assay technique [13] . The procedure was designed to incorporate nuclei and large organelles in the final homogenate. Oxygen consumption was measured in the presence of 5-HT and tryptamine.
Determination of M A 0 metabolites using liquid chromatograhy
Trypanosoma brucei brucei trypomastigotes and rat:liver homogenate were separately incubated in HGRP buffer enriched with 5-HT and tryptamine for 2 h. The control solutions incorporated neat buffer, buffer with tryptamine, buffer with 5-HT and liver homogenate alone. The viability of the trypanosomes was checked microscopically half hourly. At the end of the incubation period, protein was precipitated using trichloroacetic acid and centrifuged off.
The supernatant was subjected to high -. . .~. analysis on RP C18 silica column (250 x 4.6 &, 5 pn). 'The mobile phase consisted of acetate buffer-acetonitrile, pH 4.76, pumped on a gradient for optimum elution. The eluents were monitored at 265 nrn.
Liver M A 0 activity
Rat liver homogenates were incubated in homogenizing buffer enriched with KCN (3.33 mM) containing tryptamine and 5-HT. Oxygen consumption was measured and the enzyme activity recorded. The results were fitted into the Michaelis-Menten (MM) and LineweaverBurke (LB) plots to obtain the V, , and K, values [14] .
Liver M A 0 inhibition
Two known M A 0 inhibitors clorgylline (MAO-A) and L-deprenil (MAO-B) were used for this purpose). The substrates, used were 5HT and 2-phenylethylarnine. Initially 0.1 ml of KCN (100 rnM), 0.3 ml rat liver homogenate and 0.1 rnl of the inhibitor solution were added into the reaction chamber. After 2 min, 0.1 ml' of substrate solution was added. The oxygen consumption per gram of protein was determined. The control setup did not incorporate the inhibitor substances. Percentage inhibition was calculated with reference to the controls. This procedure was repeated for 6 inhibitor concentrations rangng 0-200 pM. From a plot of percentage inhibition against concentration, the ICso was determined.
M A 0 inhibition by test compounds
The compounds were dissolved in dimethylsulfoxide (DMSO) and introduced into rat liver homogenates. The substrates, 5HT and 2-phenylethylamine were then added and the oxygen consumption measured. The percentage inhibition of M A 0 by the test compounds is shown in table 1. Compound 2 was further investigated for the lunetics of its MA0 inhibition. The compound was applied in the concentration range 10-100 pM against 3 concentrations of the two substrates (K,, 2K, and 3Km). The data obtained for MAO-A were analyzed and fitted into a Dixon plot [15] . The ICso for the compound was determined as described above.
liquid chromatography (LC)
.
RESULTS AND DISCUSSION
of MA0 activity is not due to non-penetration of the substrates in the parasite cells. This Figure 2 shows the oxygen consumption of live observation is hrther supported by the HPLC parasites and liver homogenates in the presence assay, whereby no peaks corresponding to MA0 of M A 0 substrates. The parasites did not show metabolites were detected. This being a highly M A 0 activity as indicated by the level curve.
sensitive method (compared to the oxygen Furthermore, even T b. brucei homogenates electrode technique) trace amounts of substrates produced the same results. This shows that lack could be detected. convert 5-HT to 5-hydroxylindole ethanol via the transaminase pathway [20] . However, The antitrypanosomal activity of the compounds trypanosomes are unable to convert tryptophan tested does not occur through parasite M A 0 to 5-HT [I] . The neuropathology of inhibition since the parasites are devoid of M A 0 trypanosomiasis needs to be studied further. .
Out of the nine tryptophan analogs tested for MA0 inhibition, only compounds 2 and 3 showed significant activity against mammalian M A 0 (Table 1) Compound 2 (pM) compound 2 inhibits MAO-A in a noncompetitive way. 
IS] = 2K,
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CONCLUSION
The results obtained from the study show that T 6. brucei do not metabolize 5-HT and tryptamine implying that the parasites have no measurable MA0 activity. This finding suggests that novel tryptophan analogs, which have been found to have antitrypanosomal activity, do not act by interfering with tryptophan metabolism as originally expected. This is supported by the observation that these compounds do not inhibit mammalian MAO. The thiazolidine thione derivatives of indole (with no acetylenic function), 2 and 3, which weakly inhibit MA0 in a non-competitive way possess no antitrypanosomal activity.
